2Bush K,Jacoby G A, Medeiros A . A functional classification scheme for β-lactamases and its correlation with molecular structure [ J ]. Antimicroh Agents Chemother, 1995,39 : 1211.
3Perez M O, Perez -Moreno M, Carulla M, et al. Mechanism of reduced susceptibility to amoxicillin -clavulanic acid in Escherichia coli strains from the health region of Tortosa ( Catalonia, Spain) [ J ]. Clin Microbiol Infect ,2004,10:234.
5Kaye K S, Gold H S, Schwaber M J, et al. Variety of beta - lactamases produced by amoxicilliu - clavulanate - resistant Escherichia coli isolated in the northeastern United States [ J ]. Antimicrob Agents Chemother,200d ,48 (5) :1520 - 1525.
6Bradford P A. Extended - spectrum beta -lactamase in the 21^st century : Characterization, epidemiology, and detection of this important resistance threat [ J ]. Clin Microbiol Rev,2001,14 (4) :933 - 951.
7Chaibi E B, Sirot D, Paul G, et al. Inhibitor - resistant TEM β - lactamase : Phenotypic, genetic, and biochemical characteristics [ J ]. J Antimicrob Chemother, 1999,43:44.
8CLSI. Performance standards for antimicrobial susceptibility testing: Approved Standard M100 -S18 [ S]. CLSI, Wayne, PA, USA ,2007.
9CLSI. Performance standards for antimierobial disk and dilution susceptibility tests for bacteria isolated from animals ;Approved standard- third edition[ S]. CLSI document M31 -A3, Wayne,PA.Clinical and Laboratory Standards Institute ,2008.
10Aroin C ,Labia R,Dubois V,et al. TEM -80,a novel inhibitor-resistant beta -lactamase in a clinical isolate of enterobacter cloacae [ J ]. Antimicrob Agents Chemother, 2002,46 ( 5 ) : 1183 - 1189.
